MAP2K1 and breast cancer: The influence of TAK-733 MEK1 inhibitor on miR-221 expression was further analyzed using MDA-MB-231 breast cancer cells, 48 h after treatment with 1 μM and 10 μM TAK-733 combined with 4 Gy irradiation.